Investor Awareness: Legal Deadlines for Class Action Suits

Author: Owen Jenkins Updated: 10-13-2025 08:20 AM

Important Deadlines for Shareholder Class Action Lawsuits

Holzer & Holzer, LLC emphasizes the importance for investors to be aware of critical deadlines for seeking lead plaintiff status in ongoing class action lawsuits. These lawsuits involve significant allegations against notable companies, namely PubMatic, Inc. (NASDAQ: PUBM), C3.ai, Inc. (NYSE: AI), and Nutex Health Inc. (NASDAQ: NUTX).

About PubMatic, Inc.

The shareholder class action lawsuit against PubMatic, Inc. alleges that the company made false or misleading statements regarding its revenue generation from a key demand-side platform (DSP) client. Investors who purchased PubMatic shares between February 27 and August 11 in a specified timeframe and experienced substantial losses are encouraged to consider their legal rights.

Key Action Date for PubMatic

Investors must note that the deadline to petition the court for lead plaintiff status in the PubMatic case is October 20.

Overview of C3.ai, Inc.

C3.ai, Inc. is facing a class action alleging that it provided materially misleading information regarding its business growth. This legal action targets investors who bought shares between February 26 and August 8 during a crucial period of the company's operations. If you are among those who suffered losses, it is vital to explore your legal options promptly.

C3.ai Important Date

The deadline to apply for lead plaintiff status for C3.ai is October 21.

Details on Nutex Health Inc.

The class action lawsuit against Nutex Health Inc. accuses the company of issuing misleading statements about its revenue sustainability. This case affects shareholders who made purchases from August 8 to August 14. If you find yourself in this group and have incurred a significant loss, you should evaluate your legal chances and act swiftly.

Nutex Health Critical Deadline

The final date to seek lead plaintiff status in the Nutex Health lawsuit is also October 21.

Holzer & Holzer, LLC: Your Legal Ally

Holzer & Holzer, LLC has built a reputation over the years as a robust advocate for investors. This prominent law firm has successfully recovered millions of dollars for shareholders affected by fraud and corporate misbehavior. Established in the year 2000, the firm is led by experienced attorneys who remain dedicated to investor rights.

Contacting Holzer & Holzer

If you have questions about your legal rights or want to discuss your situation, don’t hesitate to reach out. You can contact Corey D. Holzer, Esq. directly at (888) 508-6832 or via email. Additionally, more information can be found on their official website.

Frequently Asked Questions

What is the purpose of this article?

This article alerts investors about impending legal deadlines concerning shareholder class action lawsuits against several companies.

Who should take action based on this information?

Investors who have purchased shares of PubMatic, C3.ai, or Nutex Health during specified periods and have incurred losses should seek legal counsel.

What are the main companies involved?

The companies involved are PubMatic, Inc., C3.ai, Inc., and Nutex Health Inc.

How can I reach Holzer & Holzer for legal help?

Investors can contact Corey D. Holzer, Esq. directly via the provided phone number or email.

What happens if I miss the deadline?

Missing the deadline may prevent you from participating in the lawsuit, thereby losing the chance to recover potential losses.

About The Author

Hi there I'm 38-year-old author and financial consultant Owen Jenkins. Having worked in the financial sector for more than ten years, I am well-versed in the subtleties and complexity that mold our financial environment. Following a degree in finance, I worked in a number of financial institutions honing my abilities in market analysis, financial planning, and investment strategies.

My love is teaching others about investing and personal finance. My goal in writing many books and articles has been to demystify financial ideas and give readers the information they need to make wise financial decisions. I write with a direct, useful style that emphasizes doable suggestions for daily living.

Along with writing, I lead webinars and seminars where I impart knowledge on how to successfully negotiate the financial world. I also write for financial journals and show up as a guest expert on financial news programs a lot. Whether they are new to investing or want to improve their approach, my mission is to enable people to take charge of their financial futures.

Beyond work, I like to hike, play the guitar, and spend time with my family. I think that balance is crucial and want to encourage people to strike a balance between their financial aspirations and their hobbies. I want to help people succeed and achieve financial security through my work, so having a good influence.

Contact Owen Jenkins privately here. Or send an email with ATTN: Owen Jenkins as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.